Nicolas Gaboriaud‐Kolar

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases

Vassilios Myrianthopoulos, Marina Kritsanida, Nicolas Gaboriaud‐Kolar et al. · ACS Medicinal Chemistry Letters · 2012 · 68 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts

Aimilia D. Sklirou, Nicolas Gaboriaud‐Kolar, Issidora S. Papassideri et al. · Scientific Reports · 2017 · 67 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

From Drug Screening to Target Deconvolution: a Target-Based Drug Discovery Pipeline Using Leishmania Casein Kinase 1 Isoform 2 To Identify Compounds with Antileishmanial Activity

Émilie Durieu, Eric Prina, L Olivier et al. · Antimicrobial Agents and Chemotherapy · 2016 · 57 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Oxidative Burst Inhibitory and Cytotoxic Indoloquinazoline and Furoquinoline Alkaloids from <i>Oricia suaveolens</i>

Jean Duplex Wansi, M. Ahmed Mesaik, David Dako Chiozem et al. · Journal of Natural Products · 2008 · 50 citations

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery and Optimization of a Selective Ligand for the Switch/Sucrose Nonfermenting-Related Bromodomains of Polybromo Protein-1 by the Use of Virtual Screening and Hydration Analysis

Vassilios Myrianthopoulos, Nicolas Gaboriaud‐Kolar, C. Tallant et al. · Journal of Medicinal Chemistry · 2016 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Molecular Biology +17